| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |